Cargando…

Multimodal treatments for advanced prostate cancer

Detalles Bibliográficos
Autores principales:	Faiena, Izak, Kim, Isaac Y., Jang, Thomas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349456/ https://www.ncbi.nlm.nih.gov/pubmed/30719221 http://dx.doi.org/10.18632/oncotarget.26525

Ejemplares similares

Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
por: Movassaghi, Miyad, et al.
Publicado: (2021)

Prevention of erectile dysfunction after radiotherapy for prostate cancer
por: Faiena, Izak, et al.
Publicado: (2014)

Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review)
por: FAIENA, IZAK, et al.
Publicado: (2014)

Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers
por: Faiena, Izak, et al.
Publicado: (2017)

Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
por: Faiena, Izak, et al.
Publicado: (2018)

Advances in Prostate Cancer Research and Treatment
por: Livi, Lorenzo, et al.
Publicado: (2014)

Advances in Radiotherapy for Prostate Cancer Treatment
por: Podder, Tarun, et al.
Publicado: (2016)

Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer
por: Kaochar, Salma, et al.
Publicado: (2019)

Pushing the boundaries: emerging role of radical prostatectomy as part of multimodal treatment for oligometastatic prostate cancer
por: Sosnowski, Roman, et al.
Publicado: (2023)

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
por: Terlizzi, Mario, et al.
Publicado: (2022)

Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer
por: Farber, Nicholas J., et al.
Publicado: (2018)

Rectal Cancer: Multimodal Treatment Approach
por: Pramateftakis, Manousos-Georgios, et al.
Publicado: (2012)

Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy
por: Sundi, Debasish, et al.
Publicado: (2019)

Radical prostatectomy in locally advanced cancer – an indispensable onset of multimodal therapy?
por: Malewski, Wojciech, et al.
Publicado: (2017)

Special Issue “Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning”
por: Tokas, Theodoros
Publicado: (2022)

Advances in Localized Prostate Cancer Management
por: Samadi, David B., et al.
Publicado: (2018)

Editorial for the Special Issue on Multimodality and Sequential Therapy in Locally Advanced Head and Neck Cancer
por: Riva, Giuseppe, et al.
Publicado: (2022)

Multimodal Treatment of Gastric Cancer: Surgery, Chemotherapy, Radiotherapy, and Timing
por: Bernini, Marco, et al.
Publicado: (2012)

Multimodality and Sequential Therapy in Locally Advanced Head and Neck Cancer: A Preface to the Special Issue
por: Riva, Giuseppe, et al.
Publicado: (2021)

Targeted nanoparticles for multimodal imaging of the receptor for advanced glycation end-products
por: Drake, Lindsey R., et al.
Publicado: (2018)

Prostate cancer screening and management: Caution against over-interpreting the results of the latest study, ProtecT
por: Kim, Isaac Yi
Publicado: (2023)

Poly (ADP-ribose) polymerase inhibitor: A new horizon in advanced prostate cancer treatment
por: Kang, Minyong, et al.
Publicado: (2023)

Intracrine androgen biosynthesis in renal cell carcinoma
por: Lee, Geun Taek, et al.
Publicado: (2017)

Multimodality Treatment in Metastatic Gastric Cancer: Working Together to Tailor the Continuum of Care
por: Petrillo, Angelica
Publicado: (2021)

Developing immunotherapy strategies in the treatment of prostate cancer
por: Gulley, James L., et al.
Publicado: (2016)

Translational Research in Colorectal Cancer: Current Status and Future Perspectives of Multimodal Treatment Approach
por: Marano, Luigi, et al.
Publicado: (2019)

Ganoderic Acid in the Treatment of Prostate Cancer
por: Ameri, Abdulghani
Publicado: (2012)

Assessment of real-world application of advanced prostate cancer management in Japan
por: Aragon-Ching, Jeanny B.
Publicado: (2022)

Editorial for the Special Edition of Advanced Prostate Cancer: From Bench to Bedside
por: Saad, Fred
Publicado: (2023)

I BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES
por: COIMBRA, Felipe José Fernandez, et al.
Publicado: (2015)

Multimodal Imaging in Ophthalmology
por: Toto, Lisa, et al.
Publicado: (2016)

Multimodal Imaging of the Fundus
por: Hayashi, Atsushi, et al.
Publicado: (2013)

Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
por: Lam, Marnix G. E. H., et al.
Publicado: (2008)

Very high-risk prostate cancer: multimodality treatment will be the new frontier
por: Campobasso, Davide, et al.
Publicado: (2017)

Multimodal therapy in the treatment of metastatic prostate cancer: A case report
por: Omidele, Olamide O., et al.
Publicado: (2018)

Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer
por: Narayanan, Ramesh, et al.
Publicado: (2017)

Editorial for the Special Issue on High-Risk Localized and Locally Advanced Prostate Cancer
por: Izumi, Kouji
Publicado: (2023)

Targeting protein myristoylation for the treatment of prostate cancer
por: Sulejmani, Essilvo, et al.
Publicado: (2018)

Treatment of metastatic prostate cancer after STAMPEDE
por: Wolf, Philipp
Publicado: (2017)

Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer
por: Ghiam, Alireza Fotouhi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a3qcah6deljaspata9r0e77l2j